Interventions for increasing chlamydia screening in primary care: a review

Ginige, Samitha; Fairley, Christopher K.; Hocking, Jane S.; Bowden, Francis J.; Chen, Marcus Y.
January 2007
BMC Public Health;2007, Vol. 7 Issue 1, p95
Academic Journal
Background: Despite guidelines recommending opportunistic chlamydia screening of younger women, screening rates in some countries remain low. Our aim was to review the evidence for specific interventions aimed at increasing chlamydia screening rates in primary care. Methods: A Medline search was conducted for controlled trials that assessed the effectiveness of interventions aimed at improving chlamydia screening rates in primary health care settings. The Medline search was done for studies in English published prior to December 2005 using the following key words: chlamydia, screening, intervention, primary care and GPs. In addition, the references cited in the articles were reviewed. Studies in English published prior to December 2005 were reviewed. Results: Four controlled studies met the inclusion criteria - 3 were randomized studies and one was not. Strategies to increase screening rates included the use of educational packages targeting primary care physicians and the correction of barriers to screening within clinic systems. In 3 studies, the intervention was associated with an increase in screening rates of between 100% and 276% (p < 0.04). In the fourth study, the intervention was associated with a significant attenuation in declining screening rates over time (4% versus 34% decline, p = 0.04). Conclusion: There are only a limited number of randomized or controlled studies that demonstrate improved chlamydia screening of younger women in primary care.


Related Articles

  • Where do sexually active female London students go to access healthcare? Evidence from the POPI (Prevention of Pelvic Infection) chlamydia screening trial. Green, Ruth; Kerry, Sarah R.; Reid, Fiona; Hay, Phillip E.; Kerry, Sally M.; Aghaizu, Adamma; Oakeshott, Pippa // Sexually Transmitted Infections;Aug2012, Vol. 88 Issue 5, p382 

    Background Little is known about where sexually active female students access healthcare. Objectives Using data from the Prevention of Pelvic Infection (POPI) cohort, the authors aimed to: 1. Describe where sexually active female students aged ≤27 years reported accessing healthcare. 2....

  • History and Features of the Wisconsin Chlamydia Trachomatis Control Program. Addiss, David G.; Vaughn, Michael L.; Hillis, Susan D.; Ludka, Debbie; Amsterdam, Lori; Davis, Jeffrey P. // Family Planning Perspectives;Mar/Apr94, Vol. 26 Issue 2, p83 

    The article focuses on the history and features of the Chlamydia trachomatis control program of Wisconsin. Chlamydia is the most common sexually transmitted bacterial pathogen in the U.S., and an important cause of cervicitis, pelvic inflammatory disease , ectopic pregnancy and tubal infertility...

  • Associations between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease. Simms, I.; Eastick, K.; Mallinson, H.; Thomas, K.; Gohkale, R.; Hay, P.; Herrin, A.; Rogers, P.A.; Gokhale, R; Herring, A // Sexually Transmitted Infections;Apr2003, Vol. 79 Issue 2, p154 

    Objective: To evaluate the association between Mycoplasma genitalium, Chlamydia trachomatis, and pelvic inflammatory disease (PID) METHODS: A case-control methodology was used. Swab eluates were processed using the QIAamp DNA mini kit. Polymerase chain reaction (PCR) for M....

  • Q&A.  // Essence (Time Inc.);Dec2006, Vol. 37 Issue 8, p132 

    The article discusses several issues related to pelvic inflammatory disease (PID). PID is not a sexually transmitted disease. However, two common causes of PID including chlamydia and gonorrhea, can be transmitted through sexual intercourse. The symptoms of PID include fever, unusual vaginal...

  • Drug Treatment of Nonviral Sexually Transmitted Diseases: Specific Issues in Adolescents. Lehmann, C.E.; Biro, F.M. // Pediatric Drugs;2001, Vol. 3 Issue 7, p481 

    Sexually transmitted diseases (STDs) are common and happen more frequently in younger patients. These adolescents have unique risks of acquiring infection because of developing psychosocial skills, biological factors and sociocultural barriers. The clinician must be adept at identifying and...

  • Frequent occurrence of undiagnosed pelvic inflammatory disease in remote communities of central Australia. Silver, Bronwyn J.; Knox, Janet; Smith, Kirsty S.; Ward, James S.; Boyle, Jacqueline; Guy, Rebecca J.; Kaldor, John; Rumbold, Alice R. // Medical Journal of Australia;12/3/2012, Vol. 197 Issue 11/12, p647 

    The article presents an assessment of the extent of diagnosed and undiagnosed pelvic inflammatory disease (PID) in Aboriginal women in remote central Australia in 2007-2008. It notes that PID is associated with severe reproductive sequelae and has an infectious origin with chlamydia and...

  • Coping with pelvic inflammatory disease in the adolescent. Bortot, Andrea T.; Risser, Wiliam L.; Cromwell, Polly F. // Contemporary Pediatrics;Apr2004, Vol. 21 Issue 4, p33 

    Focuses on the methods to evaluate sexually active female adolescent patients for pelvic inflammatory disease. High risk of acquiring sexually transmitted diseases among adolescent girls; Importance of prompt identification and treatment of pelvic inflammatory disease; Link between the...

  • RTIs, UTIs, and PID. Moran, Julie L. // Current Health 2;Nov95 Supplement, Vol. 22 Issue 3, p1 

    Focuses on sexually transmitted diseases (STD) including reproductive tract infections (RTI), pelvic inflammatory diseases (PID), and urinary tract infections (UTI). Susceptibility of women to STDs; Chlamydia and gonorrhea; Infertility and ectopic pregnancies as side effects of PID; Practicing...

  • Formulas for estimating the costs averted by sexually transmitted infection (STI) prevention programs in the United States. Chesson, Harrell W.; Collins, Dayne; Koski, Kathryn // Cost Effectiveness & Resource Allocation;2008, Vol. 6, Special section p1 

    Background: Sexually transmitted infection (STI) prevention programs can mitigate the health and economic burden of STIs. A tool to estimate the economic benefits of STI programs could prove useful to STI program personnel. Methods: We developed formulas that can be applied to estimate the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics